A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLNour Sabiha Naji, Theodoros Karantanos, Evangeline Watson et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
CCRL2 As a Novel Target in Acute Erythroid LeukemiaNour Sabiha Naji, Theodoros Karantanos, Taha Ahmedna et al.|Blood|2024Cited by 0
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AMLTheodoros Karantanos, Suman Paul, Evangeline Watson et al.|Research Square|2025Cited by 0
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated diseaseNour Sabiha Naji, Theodoros Karantanos, Evangeline Watson et al.|Blood Advances|2026Cited by 0